Enhanced Launches the "Thor Protocol" Product Stack on Its Live Enhanced Platform

About this update from Enhanced Group Inc.

Hafthor "Thor" Björnsson Co-Creates New Performance Stack Available Now to Consumers NEW YORK, June 30, 2026 --( BUSINESS WIRE )--Enhanced (NYSE: ENHA), the elite sports competition and personalized performance products company, today announced the launch of its Thor Protocol , a comprehensive, clinician-supervised performance product stack available exclusively through its Live Enhanced consumer platform. Co-Created with Hafthor "Thor" Björnsson, World's Strongest Man Champion and the most decorated strength athlete in the history of the sport, The Thor Protocol is designed to help consumers support their strength, recovery, and physical performance under the guidance of licensed clinicians. The stack reflects the same evidence-based, medically supervised philosophy that has defined Enhanced's approach to elite athlete performance. What's in the Protocol? Thor's Protocol includes three clinician-prescribed products, each personalized to the individual's lab results and health profile. Testosterone Injections (Testosterone Cypionate) Testosterone levels decline with age. Published research shows that clinician-supervised testosterone therapy helps support lean body composition, energy, and vitality in men that qualify. Long-term data show favorable effects on body composition, mood, and metabolic markers when levels are maintained within the physiological range. Thor's protocol starts with baseline bloodwork, with dosing matched to individual needs and monitored over time. NAD+ NAD+ is a coenzyme central to cellular energy metabolism. Levels decline naturally with age, and research suggests that supporting NAD+ levels helps support cellular energy production and healthy aging. A 2025 study in Nature detailed NAD+'s role in mitochondrial function and cellular resilience, and preclinical research has shown that restoring NAD+ levels supports energy production and supports markers associated with healthy aging. The Enhanced NAD+ protocol is clinician-supervised, with dosage matched to the individual. Low-Dose Tadalafil Daily low-dose tadalafil supports healthy blood flow by promoting nitric oxide-mediated vasodilation. Clinical research supports improvements in endothelial function and vascular tone, with trials reporting better circulation and improved endothelial function. The protocol is clinician-supervised with daily dosing personalized to the individual. Why These Three Together? For strength athletes, the problem isn't one system slowing down. It's multiple systems declining at the same time: hormonal output, cellular energy, vascular function. Thor's Protocol is intended to address these areas through individualized clinician-guided treatment. Testosterone supports the hormonal foundation. NAD+ supports cellular energy production and recovery at the mitochondrial level. Tadalafil supports blood flow and vascular function. Individually, each addresses a real gap. Together, the protocol addresses multiple physiological systems through individualized clinician-guided care. Every protocol starts with a clinician review by a licensed clinician through Enhanced's healthcare provider partners. Every protocol is monitored over time, and adjusted as the individual's data changes. This is not a one-size-fits-all stack off a shelf. It's a clinician-guided protocol matched to the consumer's physiology.

View stock analysis, news, and events for Enhanced Group Inc.